Maven leads investment for ADC Bio
Maven Capital Partners is leading a funding round for ADC Bio, a Welsh biotech company. Other investors include Seneca and Finance Wales in addition to the Welsh government, which is providing a grant. The capital will be used to back the construction of a pharmaceutical manufacturing facility that will cost 8 million pounds.
Maven Capital Partners (“Maven”), one of the UK’s most active private equity houses, is pleased to announce it is leading an investment in A...